- Home
- BZ vs CORT Comparison
BZ vs CORT Comparison
Compare BZ & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BZ | CORT |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 7.6B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | BZ | CORT |
|---|---|---|
| Price | $21.44 | $81.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | $26.00 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 2.9M | 852.0K |
| Earning Date | 11-18-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.83% | N/A |
| EPS Growth | ★ 69.83 | N/A |
| EPS | 0.77 | ★ 0.87 |
| Revenue | ★ $1,125,491,208.00 | $741,172,000.00 |
| Revenue This Year | $15.60 | $23.79 |
| Revenue Next Year | $13.18 | $40.97 |
| P/E Ratio | ★ $26.44 | $94.20 |
| Revenue Growth | 12.66 | ★ 17.92 |
| 52 Week Low | $12.85 | $49.00 |
| 52 Week High | $25.26 | $117.33 |
Technical Indicators
Market Signals| Indicator | BZ | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 53.12 | 51.07 |
| Support Level | $19.52 | $78.07 |
| Resistance Level | $21.84 | $89.00 |
| Average True Range (ATR) | 0.66 | 3.47 |
| MACD | -0.02 | -0.31 |
| Stochastic Oscillator | 64.08 | 37.54 |
Price Performance
Historical ComparisonAbout BZ KANZHUN LIMITED American Depository Shares
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.